SCHEMBL159137

SCHEMBL159137

COc1cc2ncnc(Nc3ccccn3)c2cc1NC(=O)C1CCCN1C(=O)CC(C)(C)CNC(=O)CCN(C)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 1/20 0.43
XIAP P98170 1/20 0.43
EGFR P00533 13/20 0.41
ERBB2 P04626 8/20 0.41
KDR P35968 4/20 0.41
RAF1 P04049 2/20 0.41
FGFR2 P21802 2/20 0.41
FLT4 P35916 2/20 0.41
TEK Q02763 2/20 0.41
ABL1 P00519 1/20 0.41
LCK P06239 1/20 0.41
RET P07949 1/20 0.41
SRC P12931 1/20 0.41
FLT1 P17948 1/20 0.40
ERBB4 Q15303 7/20 0.39
JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157910 0.90 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL154638 0.90 EGFR (0.42) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL159136 0.79 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL15050577 0.78 CYP3A4 (0.60) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL15050359 0.78 CYP3A4 (0.60) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL159407 0.77 CYP3A4 (0.52) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL15050362 0.72 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL15050418 0.72 CYP3A4 (0.77) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL159072 0.72 CYP3A4 (0.77) CYP3A4CYP2C9CYP2C19XIAPEGFR
SCHEMBL15050415 0.72 CYP3A4 (0.77) CYP3A4CYP2C9CYP2C19XIAPEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611797-A2 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS Hanmi Science Co., Ltd. (KR) 2013-07-10 EP disclosed
WO-2012030160-A2 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS HANMI HOLDINGS CO., LTD. (KR) 2012-03-08 WO disclosed